Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dimyristoylphosphatidylcholine
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Injection
01
Overview
Dimyristoylphosphatidylcholine is a synthetic phospholipid used in liposomes and lipid bilayers for studying biological membranes. It forms micelles with a hydrophobic core, allowing it to solubilize lipophilic drugs while maintaining a hydrophilic outer portion, thus increasing solubility in aqueous environments like blood or gastrointestinal tracts[2][3][6].
- Brand names
- Abelcet
- Other names
- DL-dimyristoylphosphatidylcholineDMPC1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE
Beyond the preview
Go deeper on dimyristoylphosphatidylcholine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dimyristoylphosphatidylcholine.